Free Trial
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

LifeMD logo
$12.54 -0.39 (-2.98%)
Closing price 07/3/2025 03:53 PM Eastern
Extended Trading
$12.44 -0.10 (-0.80%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LifeMD Stock (NASDAQ:LFMD)

Key Stats

Today's Range
$12.24
$13.09
50-Day Range
$6.09
$15.06
52-Week Range
$3.99
$15.84
Volume
902,588 shs
Average Volume
1.08 million shs
Market Capitalization
$570.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

LifeMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

LFMD MarketRank™: 

LifeMD scored higher than 22% of companies evaluated by MarketBeat, and ranked 2530th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    LifeMD has only been the subject of 2 research reports in the past 90 days.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.56) to $0.12 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeMD is -36.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeMD is -36.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about LifeMD's valuation and earnings.
  • Percentage of Shares Shorted

    9.84% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 1.99%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.84% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 1.99%, indicating that investor sentiment is decreasing.
  • News Sentiment

    LifeMD has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for LifeMD this week, compared to 2 articles on an average week.
  • Search Interest

    Only 9 people have searched for LFMD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,119,172.00 in company stock.

  • Percentage Held by Insiders

    18.40% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
LifeMD: An Overlooked GLP-1 Beneficiary
LifeMD: Getting Frothy
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $4.95 on January 1st, 2025. Since then, LFMD shares have increased by 153.4% and is now trading at $12.5450.

LifeMD, Inc. (NASDAQ:LFMD) announced its quarterly earnings data on Tuesday, May, 6th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.05. The business earned $65.70 million during the quarter, compared to analysts' expectations of $62.47 million.
Read the conference call transcript
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
5/06/2025
Today
7/04/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$18.00
Low Stock Price Target
$7.00
Potential Upside/Downside
-4.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.88 million
Pretax Margin
-4.17%

Debt

Sales & Book Value

Annual Sales
$212.45 million
Price / Cash Flow
N/A
Book Value
($0.09) per share
Price / Book
-139.39

Miscellaneous

Free Float
37,086,000
Market Cap
$570.17 million
Optionable
Optionable
Beta
2.40
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners